A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...

Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...

Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer SEATTLE — Jan. 28, 2025 — A new study shows that oral fecal microbiota ...

Dr. Armin Rashidi studies how the microbiome, the community of bacteria living in and on our bodies, influences patients’ outcomes after intensive therapy for blood cancers. Our health is intimately ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

The Clinical Research and Translational Science and Therapeutics Divisions are hosting a scientific symposium in honor of Dr. Rainer Storb on Friday, June 27, 2025. Dr. Storb has been a pivotal figure ...

Fred Hutch Cancer Center Senior Vice President and Director of the Clinical Research Division Sara Hurvitz, MD, recently received the inaugural Smith Family Endowed Chair in Women’s Health. The new ...

The Howard Hughes Medical Institute has named Grant King, PhD, a Hanna H. Gray Fellow — investing up to $1.5 million for up to eight years to help King achieve his goal of running his own lab. He is ...

A new study from a postbaccalaureate researcher in Mark Roth’s lab at Fred Hutch Cancer Center, Cameron Suraci, shows that ...

Physician, Fred Hutch Acting Assistant Professor, Clinical Research Division, Fred Hutch Acting Assistant Professor, Division of Hematology and Oncology, University of Washington School of Medicine I ...